© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Myocarditis and dilated cardiomyopathy
An inflammatory link
Department of Internal Medicine, J527 Kentucky Clinic 0284, University of Kentucky, Lexington, KY 40506, USA
*Tel.: +1-859-257-5116; fax: +1-859-257-8364. Email address: jmason12{at}charter.net
Myocarditis is a complex disease because multiple pathogenetic mechanisms play a role. While these mechanisms appear to act in a chronological cascade, they undoubtedly overlap in some cases, rendering diagnosis and treatment difficult. Ultimately, dilated cardiomyopathy (DCM) may result. A multitude of still-circumstantial evidence points to a major role of viral myocarditis in the etiology of DCM. The common presence of viral genetic material and viral proteins in the myocardium of patients with DCM provides the most compelling evidence, but proof of causality is still lacking. Nevertheless, because of the striking increase in heart failure prevalence in recent years, anti-viral and anti-inflammatory therapies should be developed for their potential to prevent or ameliorate DCM.
KEYWORDS Myocarditis; Dilated cardiomyopathy; Autoimmunity; Heart failure; Immunosuppression
Time for primary review 21 days.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Szalay, M. Sauter, M. Haberland, U. Zuegel, A. Steinmeyer, R. Kandolf, and K. Klingel Osteopontin: A Fibrosis-Related Marker Molecule in Cardiac Remodeling of Enterovirus Myocarditis in the Susceptible Host Circ. Res., April 10, 2009; 104(7): 851 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dennert, H. J. Crijns, and S. Heymans Acute viral myocarditis Eur. Heart J., September 1, 2008; 29(17): 2073 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kindermann, M. Kindermann, R. Kandolf, K. Klingel, B. Bultmann, T. Muller, A. Lindinger, and M. Bohm Predictors of Outcome in Patients With Suspected Myocarditis Circulation, August 5, 2008; 118(6): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Weber, M T Ashworth, R A Risdon, M Malone, M Burch, and N J Sebire Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series Arch. Dis. Child., July 1, 2008; 93(7): 594 - 598. [Abstract] [Full Text] [PDF] |
||||




